Paradeep Phosphates Q1 FY27 Revenue Surges 36% to ₹6,124 Crore; Approves ₹250 Cr AlF3 Plant Investment
Paradeep Phosphates Ltd reported Q1 FY27 revenue of ₹6,124 crore, up 36% YoY. EBITDA increased 24% to ₹764 crore, and PAT was ₹393 crore, also up 24% YoY. Sales volume grew 4% to 9.85 LMT. The company also approved a ₹250 crore investment for a new Aluminium Fluoride (AlF3) plant.
The substantial revenue growth and the significant investment in a new manufacturing facility are expected to have a considerable positive impact on the company's financial performance and market position.
The company reported significant year-on-year growth in revenue, EBITDA, and PAT, along with an approved strategic investment in a new plant, indicating positive financial health and future growth prospects.
Paradeep Phosphates Limited (PPL) announced its financial results for the quarter ended June 30, 2026, reporting a strong performance despite global uncertainties and volatile raw material prices. Revenue from operations increased by 36% year-on-year to ₹6,124 crore. EBITDA rose by 24% to ₹764 crore, Profit Before Tax (PBT) also grew by 24% to ₹526 crore, and Profit After Tax (PAT) stood at ₹393 crore, marking a 24% year-on-year increase. Sales volume saw a 4% growth, reaching 9.85 lakh metric tonnes (LMT).
Mr. N. Suresh Krishnan, Managing Director & CEO, highlighted the company's robust operational and financial performance, attributing it to integrated operations and agility in navigating global volatility. He also confirmed that the Phos Acid expansion project (Phase 1), increasing capacity from 500,000 MTPA to 700,000 MTPA at Paradeep, is on track.
Furthermore, the Board of Directors approved an investment proposal of ₹250 crore for setting up an Aluminium Fluoride (AlF3) plant at Paradeep. This strategic move aligns with PPL's objective to diversify into related industrial chemicals, strengthen its non-subsidy portfolio, and create long-term shareholder value by converting by-products into value-added specialty and industrial chemicals.
What to do with a filing like this
Paradeep Phosphates Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Paradeep Phosphates Limited. Read the original for the full detail.